Drugs & Biotechnology - Genmab - Market Value

26,384.00

U.S. billion dollars in 2023

Knoema, an Eldridge business, is the premier data platform and the most comprehensive source of global decision-making data in the world. Our revolutionary technology changes the way individuals and organizations discover, visualize, model, and present their data and the world's data to facilitate better decisions and better outcomes.